| FORTREA HOLDINGS DL-,001 |
| USA |
| Gesundheit |
| US34965K1079 / A3ECGB |
| K67 (Frankfurt) / FTRE (NASDAQ) |
| FRA:K67, ETR:K67, K67:GR, NASDAQ:FTRE |
| - |
| https://ir.fortrea.com/ |
|
Fortrea Holdings Inc. is a global contract research organization that provides clinical development solutions to pharmaceutical, biotechnology, and medical device companies. Fortrea Holdings Inc. supports clients across the full clinical trial lifecy..
>Volltext.. |
| 2210.48 Mio. EUR |
| 3042.86 Mio. EUR |
| 2403.85 Mio. EUR |
| 93.59 Mio. EUR |
| -76.52 Mio. EUR |
| -0.82 EUR |
| 1003.66 Mio. EUR |
| 151.43 Mio. EUR |
| 204.59 Mio. EUR |
| 0.17 |
| 1% |
| 91.47% |
| - |
| - |
| - |
| - |
| FORTREA |
| 29.10.26 |
|